Literature DB >> 30201495

Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.

Vinod Kumar1, Himanshu Vashistha2, Xiqian Lan1, Nirupama Chandel1, Kamesh Ayasolla1, Seyedeh Shadafarin Marashi Shoshtari1, Rukhsana Aslam1, Nitpriya Paliwal1, Frank Abbruscato2, Joanna Mikulak3, Waldemar Popik4, Mohamed G Atta5, Praveen N Chander6, Ashwani Malhotra1, Catherine Meyer-Schwesinger7, Karl Skorecki8, Pravin C Singhal9.   

Abstract

Human parietal epithelial cells (PECs) are progenitor cells that sustain podocyte homeostasis. We hypothesized that the lack of apolipoprotein (APO) L1 ensures the PEC phenotype, but its induction initiates PEC transition (expression of podocyte markers). APOL1 expression and down-regulation of miR193a coincided with the expression of podocyte markers during the transition. The induction of APOL1 also stimulated transition markers in human embryonic kidney cells (cells with undetectable APOL1 protein expression). APOL1 silencing in PECs up-regulated miR193a expression, suggesting the possibility of a reciprocal feedback relationship between APOL1 and miR193a. HIV, interferon-γ, and vitamin D receptor agonist down-regulated miR193a expression and induced APOL1 expression along with transition markers in PECs. Luciferase assay suggested a putative interaction between miR193a and APOL1. Since silencing of APOL1 attenuated HIV-, vitamin D receptor agonist-, miR193a inhibitor-, and interferon-γ-induced expression of transition markers, APOL1 appears to be a critical functional constituent of the miR193a- APOL1 axis in PECs. This notion was confirmed by further enhanced expression of PEC markers in APOL1 mRNA-silenced PECs. In vivo studies, glomeruli in patients with HIV, and HIV/APOL1 transgenic mice had foci of PECs expressing synaptopodin, a transition marker. APOL1 likely regulates PEC molecular phenotype through modulation of miR193a expression, and APOL1 and miR193a share a reciprocal feedback relationship.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201495      PMCID: PMC6222279          DOI: 10.1016/j.ajpath.2018.07.025

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  The regenerative potential of parietal epithelial cells in adult mice.

Authors:  Katja Berger; Kevin Schulte; Peter Boor; Christoph Kuppe; Toin H van Kuppevelt; Jürgen Floege; Bart Smeets; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

2.  Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.

Authors:  Christopher P Larsen; Barry I Freedman
Journal:  J Am Soc Nephrol       Date:  2015-01-08       Impact factor: 10.121

3.  Apolipoprotein L-I is the trypanosome lytic factor of human serum.

Authors:  Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

Review 4.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Authors:  Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

5.  Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.

Authors:  L Barisoni; M Mokrzycki; L Sablay; M Nagata; H Yamase; P Mundel
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

6.  Protein domains of APOL1 and its risk variants.

Authors:  Xiqian Lan; Hongxiu Wen; Rivka Lederman; Ashwani Malhotra; Joanna Mikulak; Waldemar Popik; Karl Skorecki; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2015-06-17       Impact factor: 3.362

7.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

8.  Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.

Authors:  Lijun Ma; Gregory S Shelness; James A Snipes; Mariana Murea; Peter A Antinozzi; Dongmei Cheng; Moin A Saleem; Simon C Satchell; Bernhard Banas; Peter W Mathieson; Matthias Kretzler; Ashok K Hemal; Lawrence L Rudel; Snezana Petrovic; Allison Weckerle; Martin R Pollak; Michael D Ross; John S Parks; Barry I Freedman
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

9.  MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.

Authors:  Leonie Kietzmann; Sebastian S O Guhr; Tobias N Meyer; Lan Ni; Marlies Sachs; Ulf Panzer; Rolf A K Stahl; Moin A Saleem; Dontscho Kerjaschki; Christoph A Gebeshuber; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

10.  Parietal cells-new perspectives in glomerular disease.

Authors:  Laura Miesen; Eric Steenbergen; Bart Smeets
Journal:  Cell Tissue Res       Date:  2017-03-30       Impact factor: 5.249

View more
  12 in total

1.  APOL1-miR-193 Axis as a Bifunctional Regulator of the Glomerular Parietal Epithelium: Maintaining Parietal Cell Phenotype versus Promoting Podocyte Differentiation.

Authors:  Joseph Jessee; Jeffrey B Kopp
Journal:  Am J Pathol       Date:  2018-09-08       Impact factor: 4.307

2.  Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.

Authors:  Vinod Kumar; Kamesh Ayasolla; Alok Jha; Abheepsa Mishra; Himanshu Vashistha; Xiqian Lan; Maleeha Qayyum; Sushma Chinnapaka; Richa Purohit; Joanna Mikulak; Moin A Saleem; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Am J Physiol Cell Physiol       Date:  2019-05-22       Impact factor: 4.249

Review 3.  APOL1 and kidney cell function.

Authors:  Vinod Kumar; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

4.  Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.

Authors:  Zhongyang Zhang; Zeguo Sun; Jia Fu; Qisheng Lin; Khadija Banu; Kinsuk Chauhan; Marina Planoutene; Chengguo Wei; Fadi Salem; Zhengzi Yi; Ruijie Liu; Paolo Cravedi; Haoxiang Cheng; Ke Hao; Philip J O'Connell; Shuta Ishibe; Weijia Zhang; Steven G Coca; Ian W Gibson; Robert B Colvin; John Cijiang He; Peter S Heeger; Barbara Murphy; Madhav C Menon
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

5.  Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.

Authors:  Alok Jha; Vinod Kumar; Shabirul Haque; Kamesh Ayasolla; Shourav Saha; Xiqian Lan; Ashwani Malhotra; Moin A Saleem; Karl Skorecki; Pravin C Singhal
Journal:  FEBS J       Date:  2019-12-02       Impact factor: 5.542

6.  MiR193a Modulation and Podocyte Phenotype.

Authors:  Alok Jha; Shourav Saha; Kamesh Ayasolla; Himanshu Vashistha; Ashwani Malhotra; Karl Skorecki; Pravin C Singhal
Journal:  Cells       Date:  2020-04-17       Impact factor: 6.600

Review 7.  Molecular Mechanisms of Renal Progenitor Regulation: How Many Pieces in the Puzzle?

Authors:  Anna Julie Peired; Maria Elena Melica; Alice Molli; Cosimo Nardi; Paola Romagnani; Laura Lasagni
Journal:  Cells       Date:  2021-01-02       Impact factor: 6.600

Review 8.  Collapsing Focal Segmental Glomerulosclerosis in Viral Infections.

Authors:  Anne K Muehlig; Sydney Gies; Tobias B Huber; Fabian Braun
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

9.  APOL1 polymorphism modulates sphingolipid profile of human podocytes.

Authors:  Manuela Valsecchi; Valentina Cazzetta; Ferdinando Oriolo; Xiqian Lan; Rocco Piazza; Moin A Saleem; Pravin C Singhal; Domenico Mavilio; Joanna Mikulak; Massimo Aureli
Journal:  Glycoconj J       Date:  2020-09-11       Impact factor: 2.916

10.  Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.

Authors:  Gizelle M McCarthy; Angelo Blasio; Olivia G Donovan; Lena B Schaller; Althea Bock-Hughes; Jose M Magraner; Jung Hee Suh; Calum F Tattersfield; Isaac E Stillman; Shrijal S Shah; Zsuzsanna K Zsengeller; Balajikarthick Subramanian; David J Friedman; Martin R Pollak
Journal:  Dis Model Mech       Date:  2021-08-05       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.